Azadyne. Proudly created with Wix.com
Azadyne is a new approach to the treatment of autoimmune diseases.
Business Model:
Revenue: $0
Employees: 1-10
Rankings
Industries / Tags:
Detailed Azadyne. Proudly created with Wix.com Information
Geographic Data
Address:
City: Dublin
State: Dublin
Zip:
Country: Ireland
Financial Info
Stage:
undisclosed
Raised Last:
$0
Raised Total:$2M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Azadyne’s novel approach to treating autoimmune disease focuses on an unexplored pathway in the body and is based on research conducted at Trinity by Associate Professor in Biochemistry Vincent Kelly, Professor of Synthetic Chemistry Professor Stephen Connon and assistant Professor in Chemistry John Michael Southern.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 3/2019 | Equity | $2M |
NCL Technology Ventures |
2/2019 | Seed Round | 1 | - |
Renaissance Capital Partners Renaissance Capital Partners |
9/2020 | Funding Round | 1 | - |
Renaissance Capital Partners Renaissance Capital Partners |
3/2019 | Seed Round | 1 | $2M |
NCL Technology Ventures NCL Technology Ventures |
9/2020 | Funding Round | 1 | - |
Renaissance Capital Partners Renaissance Capital Partners |
2/2019 | Seed Round | 1 | - |
Renaissance Capital Partners Renaissance Capital Partners |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
